논문KCI 등재
Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
2
조회
0
다운로드
0
인용
0
참고문헌
주제분류내과학
참고문헌 (10)
- Sugano K, "Kyoto global consensus report on Helicobacter pylori gastritis", Gut, 64, pp.1353~1367 (2015)
- Malfertheiner P, "European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI", Florence consensus report, 2022, ~
- 김태호, "헬리코박터 제균치료 시 프로톤펌프억제제 식전 투여가 더 좋을까?", Korean Journal of Helicobacter Upper Gastrointestinal Research, 18(2), pp.79~81 (2018), 대한상부위장관ㆍ헬리코박터학회[DOI]
- Tae Ho Kim, "Comparison of 7- and 14-Day Eradication Therapy for Helicobacter pylori with First- and Second-Line Regimen: Randomized Clinical Trial", Journal of Korean Medical Science, 35(5), pp.1~9 (2020), 대한의학회[DOI]
- Murakami K, "Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication : a phase III, randomised, double-blind study", Gut, 65, pp.1439~1446 (2016)
- Simadibrata DM, "A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases : a systematic review and meta-analysis", J Gastroenterol Hepatol, 37, pp.2217~2228 (2022)
- Kambara H, "Safety profile of vonoprazan compared with proton pump inhibitors : insight from a pharmacovigilance study", Pharmazie, 75, pp.527~530 (2020)
- Zhang M, "Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials", Clinics(Sao Paulo), 77, pp.100058~ (2022)
- Ghim JL, "Pharmacokinetics and pharmacodynamics of tegoprazan coadministered with amoxicillin and clarithromycin in healthy subjects", J Clin Pharmacol, 61, pp.913~922 (2021)
- Beom Jin Kim, "Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea", Gut and Liver, 13(5), pp.531~540 (2019), 거트앤리버 소화기연관학회협의회[DOI]
관련 논문AI추천
Role of Tegoprazan in Helicobacter pylori Eradication Therapy이진거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제4호Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?Maeda Shin, Sue Soichiro거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제6호Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot StudyChoi Il Ju, Hong Su Jin, Jeon Seong Woo, Kim Gwang Ha, Kim Jae Gyu, Park Jae Yong, Shin Sung Kwan거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제5호Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradicationDong Wook Lee, Hui Jin Bae, Ji Hey Park, Seong Woo Jeon, Su Youn Nam, Yong Hwan Kwon대한내과학회 · The Korean Journal of Internal Medicine2023 · 제38권 제4호Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication RegimensKountouras Jannis거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제4호Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial김나영, 김정목, 김지현, 백광호, 심기남, 이용찬, 이항락, 정현수, 정혜경, Choi Yoon Jin, Chun Hoon Jai, Jang Jae Young, Kim Byung-Wook, Kim Jin Il, Kim Kyoung Oh, Kim Sang Gyun, Ko Kwang Hyun, Lee Hyuk, Lim Yun Jeong, Moon Jeong Seop, Son Byoung Kwan거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제4호
이 간행물의 다른 논문 (18건)
Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection신현필pp. 454-455Role of echocardiography in acute pulmonary embolismJae-Hyeong Park, Jin Kyung Ohpp. 456-470Advanced heart failure: a contemporary approachKyeong-Hyeon Chun, 강석민pp. 471-483Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant usersHyun Seok Lee, Hyun Jung Ahn, 오동준, 남지형, Yun Jeong Limpp. 484-492Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradicationDong Wook Lee, Su Youn Nam, Seong Woo Jeon, Yong Hwan Kwon, Ji Hey Park, Hui Jin Baepp. 493-503
